Skip to content

Predicting Severe Outcomes Among Children Hospitalized With Community-acquired Pneumonia

Development and Validation of a Risk Score for Predicting Severe Outcomes Among Children Hospitalized With Community-acquired Pneumonia

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05744609
Enrollment
6000
Registered
2023-02-27
Start date
2017-01-01
Completion date
2022-12-31
Last updated
2023-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Child, Pneumonia, Prognosis

Brief summary

In this study, investigators aimed to develop and validate a risk score to predict severe outcomes (e.g., mortality and ICU admission) in children who were admitted to the Children's Hospital of Fudan University between 2017 and 2022 due to community-acquired pneumonia (CAP). The objectives were as follows. 1. Develop a risk prediction model based on demographic, comorbidity, clinical characteristics, laboratory data, and chest radiographic reports to predict severe outcomes among children hospitalized with CAP; 2. Develop a risk scoring system and determine the cut-off point; 3. Externally validate the easy-to-use risk score.

Interventions

OTHERexposures of interest: epidemiological data, clinical characteristics, laboratory data, and chest radiographic reports

epidemiological data (e.g., age, sex, and residential area), clinical characteristics (e.g., fever, cough, and wheeze), laboratory data (e.g., white blood cell, c-reaction protein, and procalcitonin), and chest radiographic reports (e.g., X-ray, CT, and ultrasound)

Sponsors

Children's Hospital of Fudan University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
29 Days to 18 Years
Healthy volunteers
No

Inclusion criteria

1. Aged between 29 days and 18 years old; 2. Admitted to hospital with signs or symptoms of acute infection (eg, fever) and acute respiratory illness (eg, cough), and radiographic evidence of pneumonia.

Exclusion criteria

1. Pneumonia developed 48 hours after admission or intubation; 2. Chronic pneumonia, tuberculosis, tracheobronchial foreign bodies, aspiration pneumonia, parasitic lung disease, and diffuse pulmonary interstitial/parenchyma disease.

Design outcomes

Primary

MeasureTime frameDescription
in-hospital mortalityfrom admission to discharge, an average of 7 daysin-hospital mortality among children hospitalized with CAP

Secondary

MeasureTime frameDescription
admission to ICUfrom admission to discharge, an average of 7 daysadmission to a intensive care unit for over 24 hours
septic shockfrom admission to discharge, an average of 7 daysoccurrence of septic shock during admission
treatment for severe pneumoniafrom admission to discharge, an average of 7 daysvasoactive agents, positive-pressure ventilation or chest drainage, or extracorporeal membrane oxygenation

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026